Manufacturers Life Insurance Company, The Trevi Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 13,074 shares of TRVI stock, worth $34,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,074Holding current value
$34,907% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
79Shares Held
50.5MCall Options Held
2.2KPut Options Held
600-
Nea Management Company, LLC Timonium, MD11.4MShares$30.4 Million2.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$19.7 Million1.34% of portfolio
-
Rubric Capital Management LP New York, NY5.56MShares$14.9 Million0.65% of portfolio
-
Viking Global Investors LP4.4MShares$11.7 Million0.06% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$9.14 Million1.01% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $156M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...